$1 million for local immunisation innovators
An estimated 2.2 million children in Nigeria and 1.1 million in Ethiopia are unvaccinated.
Save the Children’s Immunisation Accelerator, with funding from GSK, is investing $1 million in local innovators to drive progress on zero-dose and under-immunised children in both countries.
The Immunisation Accelerator will fund and support community-based innovators to develop robust context-specific evidence for solutions that address long-standing barriers to child-immunisation.
With up to $100,000 available per award, we are looking to support innovations that address supply and/or demand-side barriers, including products, services, approaches, or interventions that involve systemic, behavioral, or educational change.
The Immunisation Accelerator supports and nurtures the further development and evidencing of promising and transferable innovations that can address the challenge of vaccinating low-dose and zero-dose children. It is open to both early-stage stage ideas and those with more evidence.
Working with the immunisation eco-system
The Immunisation Accelerator works closely with the wider global health ecosystem to bring significant
innovation to the immunisation challenge.
